Develo raises $14M for AI-native paediatric operating system
What's the deal? Develo, a Los Angeles-based startup building an AI-native operating system for paediatric practices, has raised $14M in a round led by Blueprint EquityDealroom has a profile for this one. Try Dealroom →. Villain CapitalDealroom has a profile for this one. Try Dealroom →, Z21 Ventures, and Bienville Capital also participated, alongside angel investors including CentralReach chief executive officer Chris Sullens and former AllscriptsDealroom has a profile for this one. Try Dealroom → chief executive officer Paul Black. The capital will go towards R&D and customer success.
Develo's platform unifies clinical, billing, and family engagement tools into a single system — replacing the patchwork of legacy software that most paediatric practices still rely on.
Why now? Paediatric care covers more than one in three Americans and accounts for over 450 million annual visits, yet most practices still run on decades-old software. The typical setup involves a traditional electronic medical record (EMR), a standalone intake solution, and an outdated billing system — all fragmented and click-heavy.
"Practices risk further falling behind as AI innovation accelerates, especially if they look to AI bolt-ons from legacy systems to keep up," said Dr. Aaron Sin, Develo's chief executive officer and co-founder.
What could go wrong? Healthcare software is notoriously hard to sell into. Practices are slow to switch systems, and convincing providers to abandon familiar tools — even bad ones — requires significant trust and proof of ROI. Develo also faces the challenge of building for a niche vertical, which limits its total addressable market compared to horizontal health-tech platforms.
Regulatory complexity adds another layer of risk. Paediatric care involves minors, meaning stricter privacy requirements and the added complication of parent and caregiver engagement in every workflow.
The signal: Develo is still at an early growth stage, yet it pulled in a $14 million round backed by an investment fund in Blueprint Equity and angel operators drawn from late-growth healthtech incumbents like Allscripts — suggesting seasoned insiders see vertical, AI-native platforms as the successor to ageing horizontal EMR systems. If paediatric practices, which serve more than one in three Americans, prove willing to swap legacy stacks for a unified alternative, the playbook could extend to other underserved medical specialities.
Read more: smartwatch.einnews.com
